1. < Home

HPTN 083

Estimation of prevention-effective CAB-LA concentrations among men who have sex with men (MSM) and transgender women (TGW) in HPTN 083

Hanscom B, Marzinke MA, Li X, Donnell D, Bies R, Hendrix CW, Wang Z, Acuipil C, Rinehart A, Collins JW, Rooney JF, Soto Torres L,[...]

By afschroeder • November 9, 2025
Evaluation of Xpert point-of-care assays for detection of HIV infection in persons using long-acting cabotegravir for pre-exposure prophylaxis

Fogel JM, Piwowar-Manning E, Moser A, Hill T, Ahmed S, Cummings V, Mostafa HH, Wang Z, Jennings A, Gallardo-Cartagena JA, Figueroa MI, St Clair M,[...]

By sjmartinez • July 10, 2024
Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

Marzinke MA, Fogel JM, Wang Z, Piwowar-Manning E, Kofron R, Moser A, Bhandari P, Gollings R, Bushman LR, Weng L, Halvas EK, Mellors J, Anderson[...]

By sjmartinez • March 31, 2023
Evaluating group-sequential non-inferiority clinical trials following interim stopping: The HIV Prevention Trials Network 083 trial

Hanscom BS, Donnell DJ, Fleming TR, Hughes JP, McCauley M, Grinsztejn B, Landovitz RJ, Emerson SS. Evaluating group-sequential non-inferiority clinical trials following interim stopping: The[...]

By sjmartinez • November 29, 2022